IN MEMORIAM, P. Kayembe K, et F. L epira B. ILS NOUS LEGUENT EGALEMENT CE MERVEILLEUX TRAVAIL
Prevalence of Undiagnosed Hypertension among the Hypertensives Living in the City of Boma. Republic Democratic Republic of the Congo
Blaise Makoso Nimi 1,2, François Lepira Bompeka1,Benjamin Longo Mbenza1,4, Roland Vangu Vangu 2,4, Gedeon Longo Longo2,4 Aliocha Nkodila5, Memoria Makoso Nimi2 , Patrick Kayembe Kalambayi6and Jean René M’Buyamba-Kabangu1.
1 Department of Internal Medicine, University of Kinshasa, DRCongo
2 University Kasa Vubu School of Medicine, Boma, DRCongo
3″Lomo Medical » Center, Kinshasa, DRCongo
4Department of Gynecoligy , University of Kinshasa , DRCongo
5« Cité des Aveugles » Medical Center, Kinshasa, DRCongo
6Kinshasa School of Public Health, University of Kinshasa, DRCongo
Blaise Makoso, MD University of Kinshasa, PO Box 123 Kin XI
Undiagnosed and uncontrolled hypertension are responsible for several cardiovascular complications, particularly in countries with limited resources. The objective of this study was to assess the extent of undiagnosed hypertension in the adult hypertensive in Boma.
We conducted a cross-sectional study using the WHO step wise questionnaire, from March 1 to April 15, 2018. The study included all known hypertensive adults and all those who had high blood pressure during the study. The parameters of interest were age, sex, anthropometric measure and behavioral factors. Independent factors associated with undiagnosed hypertension were identified using logistic regression analysis with p <0.05 was significant
The prevalence of undiagnosed hypertension was 56. 1%. Only 47.9% had controlled BP among known hypertensive. Young age (p<0.001), no FH-HT (p= 0.030), Low SES (p<0.012) have emerged as the main determinant associated with undiagnosed hypertension.
Undiagnosed hypertension was characterized by a high prevalence and suboptimal BP control. Therapeutic lifestyle changes and pharmacological treatment are needed for those hypertensive participants. Keywords: Prevalence, Undiagnosed hypertension, Boma